KEY TAKEAWAY:According to Megan at STAT news “President Trump’s full budget proposal comes with massive cuts to Medicaid and the agencies and programs that run the nation’s public health and biomedical research efforts”. And where are the pharma leaders? Silent as every other major medical organization opposes new changes that could hurt 20 million patients.
Consider Trump’s proposal via STAT:
Medicaid’s budget would be slashed $610 billion over the next decade — in addition to the $839 billion that would be cut if the AHCA passes. It isn’t clear yet where in the program those cuts would take place.
The NIH budget would be cut by 18 percent from 2017 spending levels, down to $26 billion. The National Cancer Institute, which falls under the NIH umbrella, would see a budget cut of 19 percent.
The CDC budget would take a 17 percent cut, which shakes out to a $6.3 billion decrease in funding. Spending on HIV/AIDS, hepatitis, sexually transmitted infections, and tuberculosis prevention would be reduced by 17 percent. The CDC’s global health program — which is responsible for helping fight disease outbreaks abroad — would take an 18 percent cut.
- The FDA would see a 31 percent decrease in direct government funding, leaving the agency with a $1.9 billion budget. The administration is hoping to offset that loss with a $1.3 billion increase in revenue from the user fees that drug and medical device makers pay when applying for FDA approval.
[inlinetweet prefix=”” tweeter=”” suffix=””]This comes at a time when $26,944 is this year’s estimate of what healthcare will cost a family of four in the U.S.[/inlinetweet], based on the 2017 Milliman Medical Index (MMI). This is based on the projected total costs of healthcare for a family covered by an employer-sponsored PPO plan.
While some pharma CEO’s have responded, Lilly’s for example, other are remaining too damn quiet and need to get their asses off the sideline and speak out against these cuts which could set American healthcare back 50 years.